Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?

BACKGROUND: Decision-makers may consider vaccinating girls and boys with different HPV vaccines to benefit from their respective strengths; the quadrivalent (HPV4) prevents anogenital warts (AGW) whilst the bivalent (HPV2) may confer greater cross-protection. We compared, to a girls-only vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Drolet, Mélanie, Boily, Marie-Claude, Van de Velde, Nicolas, Franco, Eduardo L., Brisson, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694081/
https://www.ncbi.nlm.nih.gov/pubmed/23840589
http://dx.doi.org/10.1371/journal.pone.0067072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694081/
https://www.ncbi.nlm.nih.gov/pubmed/23840589
http://dx.doi.org/10.1371/journal.pone.0067072

Ejemplares similares